Search

Search Results

• 

  Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  https://doi.org/10.4081/btvb.2024.129

  694

  PDF: 219
• 

  Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

  Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

  27-07-2022

  https://doi.org/10.4081/btvb.2022.34

  4571

  PDF: 387

  Supplementary Files: 114
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  https://doi.org/10.4081/btvb.2022.10

  1044

  PDF: 330

  APPENDIX: 67
• 

  Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

  Mosaad Almegren

  12-10-2023

  https://doi.org/10.4081/btvb.2023.85

  314

  PDF: 146
• 

  Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

  Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

  14-07-2022

  https://doi.org/10.4081/btvb.2022.36

  1029

  PDF: 221
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  https://doi.org/10.4081/btvb.2022.42

  850

  PDF: 282
• 

  Stroke in women: anticoagulation in a complicated puzzle

  Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

  26-08-2024

  https://doi.org/10.4081/btvb.2024.137

  1073

  PDF: 283
• 

  Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

  Francesco Cicconi

  05-07-2024

  https://doi.org/10.4081/btvb.2024.128

  1282

  PDF: 339
• 

  New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

  Mehrie H. Patel, Alok A. Khorana

  16-05-2024

  https://doi.org/10.4081/btvb.2024.113

  500

  PDF: 236
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1448

  PDF: 307
• 

  The new era of anticoagulation: factor XI and XII inhibitors

  Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

  07-06-2023

  https://doi.org/10.4081/btvb.2023.76

  2131

  PDF: 856
• 

  Unveiling the “common soil” of cardiovascular disease and cancer

  Licia Iacoviello, Maria Benedetta Donati

  24-02-2025

  https://doi.org/10.4081/btvb.2025.167

  696

  PDF: 189
• 

  Venous thromboembolism and mortality in patients with hematological malignancies

  Kristen M. Sanfilippo, Tzu-Fei Wang

  16-05-2024

  https://doi.org/10.4081/btvb.2024.119

  659

  PDF: 233
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  https://doi.org/10.4081/btvb.2023.60

  656

  PDF: 298